Search

everythinglearnresearchcommunity

for

Search:↓

The guidelines suggest using various treatments, including antidepressants and steroids, for alopecia areata and discuss the condition's genetic and immune aspects.

Mitochondrial stress can lead to atopic dermatitis.

ILC1-like cells can cause alopecia areata by themselves.

The new aptamer TAGX-0003 shows promise as an effective treatment for hair loss disorder alopecia areata.

Innate lymphoid cells type 1 may contribute to alopecia areata.

Langerhans cells and melanocytes migrate to the skin and hair follicles during early human development.

The conference highlighted new diagnostic tools, the role of genetics in hair loss, and emerging treatments.

Immune checkpoint inhibitors can cause scalp inflammation and hair follicle issues.

Neurogenic inflammation may play a role in hair loss in alopecia areata.

Stress-related substance P may lead to hair loss and negatively affect hair growth.

Alopecia areata is influenced by genetics and immune system factors, and better understanding could improve treatments.

Understanding the immune-related causes of Alopecia Areata has led to potential treatments like JAK inhibitors.

People with alopecia areata have fewer IL-10 producing immune cells, which might contribute to the condition.

Innate lymphoid cells type 1 may contribute to alopecia areata by damaging hair follicles.

Recent discoveries have improved our understanding of hair loss, but challenges in treatment and knowledge among specialists still exist.

Alopecia areata is a common autoimmune disease affecting hair follicles, with unclear causes and a need for better treatments.

SOCS3 treatment can prevent hair loss by stopping harmful immune responses.

A COVID-19 patient with severe hair loss did not improve with hair loss medication after stopping and restarting it due to the infection.

BST2 protein and certain T cells increase in early alopecia areata.

COVID-19 reinfection may trigger alopecia areata.

ILC1-like cells may contribute to hair loss in alopecia areata.

ILC1-like cells may contribute to hair loss in alopecia areata and could be new treatment targets.

Basal cell carcinomas may use IDO to protect themselves from the immune system.

The nail immune system is similar to hair but different from skin, with fewer immune markers.

Alopecia areata is caused by the immune system attacking hair follicles.

Stress may contribute to hair loss in alopecia areata by affecting immune responses and cell death in hair follicles.

JAK inhibitors may reverse early hair loss, but prolonged inflammation can cause permanent hair loss.

Hair follicle stem cells might help treat traumatic brain injury.

NK cells play a role in skin diseases like eczema and psoriasis.

Higher CD8+ T cell levels are linked to Alopecia areata in Iraqi patients.